GO
Loading...

Pharmaceuticals

More

  • Africa escalates fight against Ebola as cases surge Friday, 1 Aug 2014 | 11:17 AM ET

    West African leaders and international health groups have stepped up plans to combat the world’s worst outbreak of the deadly Ebola virus.

  • MUMBAI, Aug 1- Pfizer Ltd, the Indian unit of U.S. drugmaker Pfizer Inc, said on Friday it locked out staff at its Mumbai drug factory after some employees tried to disrupt production lines and threatened management.

  • Valeant forecast overshadows strong quarter Thursday, 31 Jul 2014 | 1:04 PM ET

    Shares of Valeant Pharmaceuticals plunged 7 percent Thursday after the company slashed its earnings and revenue forecasts. The Canadian drugmaker now expects 2014 earnings to range between $7.90 and $8.10 per share, down from a forecast it made in April for $8.55 to $8.80 per share.

  • Catalent CEO: Leading advanced drug delivery     Thursday, 31 Jul 2014 | 11:30 AM ET

    John Chiminski, Catalent Pharma Solutions CEO, discusses the company's IPO and business strategy. Chiminski the company is the world's leader in advanced drug technologies.

  • *Q2 EPS ex-items $1.23 vs $1.22 forecast. *Now sees 2014 EPS $4.50- $4.80 with Copaxone competition. TEL AVIV, July 31- Teva Pharmaceutical Industries raised its full-year profit forecast on Thursday after posting higher quarterly earnings that were due in part to the launch of several generic products in the United States.

  • JERUSALEM, July 31- Israeli industrialist Benny Landa said his campaign to improve corporate governance at Teva Pharmaceutical Industries was delivering results, despite losing a shareholder vote at the world's largest generic drugmaker.

  • Sanofi 2nd quarter profit surges Thursday, 31 Jul 2014 | 3:02 AM ET

    PARIS— French drug maker Sanofi said Thursday its earnings soared in the second quarter thanks to lower accounting charges than a year earlier, and the company lifted it full-year profit forecast.

  • LONDON, July 31- AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.

  • PARIS, July 31- French drugmaker Sanofi raised its full-year profit forecast on Thursday along with a set of stronger than expected quarterly earnings driven by its rare disease and diabetes businesses and higher sales in emerging markets.

  • LONDON, July 31- AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.

  • July 30- Israeli drugmaker Teva Pharmaceuticals Industries said on Wednesday it turned back efforts by Israeli industrialist Benny Landa to shake up the company's board of directors, with shareholders approving all of the company's proposals and board nominations.

  • *Sanofi to file drug for US and EU approval by year-end. PARIS, July 30- A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

  • Hospira beats profit estimates, raises 2014 outlook Wednesday, 30 Jul 2014 | 7:58 AM ET

    July 30- Hospira Inc, a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook.

  • Euro dampened Bayer's profits: CEO     Wednesday, 30 Jul 2014 | 5:10 AM ET

    Marijn Dekkers, CEO of Bayer, says that operationally, the group had a "very good quarter", but that profits were dampened by the strength of the euro.

  • Key witness testifies in ex-governor's trial Wednesday, 30 Jul 2014 | 4:57 AM ET

    RICHMOND, Va.— When former Virginia Gov. Bob McDonnell and his wife, Maureen, were indicted on corruption charges in January, the couple stood together at a hastily called news conference to denounce the charges.

  • Biotech drugmaker Amgen laying off at least 2,400 Tuesday, 29 Jul 2014 | 4:04 PM ET

    Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations. Amgen also raised its forecasts for its 2014 profit and revenue, driving up its shares.

  • UPS CFO Kurt Kuehn on UPS settlement     Tuesday, 29 Jul 2014 | 4:00 PM ET

    UPS CFO Kurt Kuehn on CNBC's Squawk on the Street on his company's decision to stop deliveries for illegal online pharmacies and pay $40 million to end a Federal criminal probe into its shipping practices. Rival FedEx was in court today fighting similar charges.

  • Pharma CEOs: Tax system flaws help overseas rivals Tuesday, 29 Jul 2014 | 1:35 PM ET
    Ian Read, CEO, Pfizer,  leaves the House of Commons on May 14, 2014 in London.

    Pfizer CEO Ian Read also says a potential U.S. tax holiday would be only a temporary solution.

  • *FDA lists 10 violations at Taiwan plant. July 29- Impax Laboratories Inc said the U.S. Food and Drug Administration raised concerns about the company's factory in Taiwan, casting in doubt the future of its Parkinson's drug, rytary.

  • Merck & Pfizer beat the Street     Tuesday, 29 Jul 2014 | 10:14 AM ET

    CNBC's Meg Tirrell reports both Merck and Pfizer beat earnings expectations amid patent expirations.